TCRT · Company research

Alaunos Therapeutics, Inc. Common Stock (TCRT): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

22records availableHealthcare

Stock News & Events data

Database-backed records only

22 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
TCRT Stock Explodes As Velaris Deal And Cash Raise Reset The Story - Timothy SykesTCRT Stock Explodes As Velaris Deal And Cash Raise Reset The Story Timothy SykesView source ↗Timothy SykesOct 19, 2026neutral00.6
TCRT Stock Erupts As Alaunos Unveils Velaris Deal And $350M Lifeline - StocksToTradeTCRT Stock Erupts As Alaunos Unveils Velaris Deal And $350M Lifeline StocksToTradeView source ↗StocksToTradeOct 19, 2026neutral00.6
TCRT Stock Explodes As Velaris Deal And Cash Infusion Rewire Outlook - Timothy SykesTCRT Stock Explodes As Velaris Deal And Cash Infusion Rewire Outlook Timothy SykesView source ↗Timothy SykesOct 19, 2026neutral00.6
TCRT Stock Erupts As Alaunos Lands Velaris Deal And Cash - StocksToTradeTCRT Stock Erupts As Alaunos Lands Velaris Deal And Cash StocksToTradeView source ↗StocksToTradeOct 19, 2026neutral00.6
TCRT Stock Explodes As Velaris Deal Reshapes The Story - Timothy SykesTCRT Stock Explodes As Velaris Deal Reshapes The Story Timothy SykesView source ↗Timothy SykesOct 19, 2026neutral00.6
TCRT Stock Soars After Velaris Deal And $350M Funding Wave - StocksToTradeTCRT Stock Soars After Velaris Deal And $350M Funding Wave StocksToTradeView source ↗StocksToTradeOct 19, 2026neutral00.6
TCRT Stock Quote Price and Forecast - CNNTCRT Stock Quote Price and Forecast CNNView source ↗CNNOct 17, 2026neutral00.6
Two 9.99% holders agree to back merger votes in Alaunos (TCRT)'s conditional repurchase deal. - Stock TitanTwo 9.99% holders agree to back merger votes in Alaunos (TCRT)'s conditional repurchase deal. Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
Following a roughly $350M financing, Fairmount reports a stake in Alaunos (TCRT). - Stock TitanFollowing a roughly $350M financing, Fairmount reports a stake in Alaunos (TCRT). Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
Let's take a look at the stocks that are in motion in today's session. - ChartMillLet's take a look at the stocks that are in motion in today's session. ChartMillView source ↗ChartMillOct 14, 2026neutral00.6
TCRT Stock Explodes As Velaris Deal And $350M Raise Reset Outlook - Timothy SykesTCRT Stock Explodes As Velaris Deal And $350M Raise Reset Outlook Timothy SykesView source ↗Timothy SykesOct 14, 2026neutral00.6
TCRT Stock Explodes As Velaris Deal Reshapes Alaunos - StocksToTradeTCRT Stock Explodes As Velaris Deal Reshapes Alaunos StocksToTradeView source ↗StocksToTradeOct 14, 2026neutral00.6
TCRT Stock Explodes As Velaris Deal Extends Cash Runway - StocksToTradeTCRT Stock Explodes As Velaris Deal Extends Cash Runway StocksToTradeView source ↗StocksToTradeOct 14, 2026neutral00.6
TCRT Stock Soars As Velaris Deal Transforms Alaunos - www.timothysykes.comTCRT Stock Soars As Velaris Deal Transforms Alaunos www.timothysykes.comView source ↗www.timothysykes.comOct 14, 2026neutral00.6
TCRT Stock Explodes As Velaris Deal Fuels 2029 Runway - www.timothysykes.comTCRT Stock Explodes As Velaris Deal Fuels 2029 Runway www.timothysykes.comView source ↗www.timothysykes.comOct 14, 2026neutral00.6
TCRT Stock Explodes After Velaris Deal And $350M Raise - StocksToTradeTCRT Stock Explodes After Velaris Deal And $350M Raise StocksToTradeView source ↗StocksToTradeOct 14, 2026neutral00.6
Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday? - BenzingaWhy is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday? BenzingaView source ↗BenzingaOct 13, 2026neutral00.6
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga12 Health Care Stocks Moving In Tuesday's Intraday Session BenzingaView source ↗BenzingaOct 13, 2026neutral00.6
Biotech Stock Alaunos Therapeutics (NASDAQ: TCRT) Sees Triple Digit Gains on Acquisition and Funding - Investorideas.comBiotech Stock Alaunos Therapeutics (NASDAQ: TCRT) Sees Triple Digit Gains on Acquisition and Funding Investorideas.comView source ↗Investorideas.comOct 13, 2026neutral00.6
Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - KalkineAlaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates KalkineView source ↗KalkineOct 9, 2026neutral00.6
Alaunos Therapeutics (TCRT) director Jaime Vieser receives 22,669 shares in lieu of board fees. - Stock TitanAlaunos Therapeutics (TCRT) director Jaime Vieser receives 22,669 shares in lieu of board fees. Stock TitanView source ↗Stock TitanOct 8, 2026neutral00.6
Board fees are paid in 20,990 shares to Alaunos Therapeutics (TCRT) director Michael Allen Jerman. - Stock TitanBoard fees are paid in 20,990 shares to Alaunos Therapeutics (TCRT) director Michael Allen Jerman. Stock TitanView source ↗Stock TitanOct 8, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.